{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T04:56:09Z","timestamp":1790571369854,"version":"4.1.0"},"reference-count":32,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Chemotherapy-induced peripheral neuropathy (CIPN) is a common neurological complication of cancer treatment that worsens function and quality of life. Topical herbal medicines are increasingly used as localized interventions for neuropathic symptoms; however, their clinical efficacy remains uncertain. This systematic review evaluated the effectiveness of topical herbal formulations for CIPN in cancer populations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We systematically searched Scopus, MEDLINE (Ovid), CINAHL, and Cochrane CENTRAL for randomized controlled trials assessing the use of topical herbal formulations in adults with CIPN. Outcomes included validated measures of CIPN pain, overall severity, sensory function, and adverse events. Risk of bias was assessed using the Cochrane Risk of Bias tool implemented in RevMan 5.3, and all procedures were conducted in accordance with PRISMA guidelines.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Five trials involving 201 participants were included, with an overall moderate risk of bias due to limited blinding and underpowered sample sizes. In breast cancer patients, henna vs. standard care significantly improved the overall severity of oxaliplatin-induced peripheral neuropathy, as measured by the CIPN Assessment Tool (\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0&amp;lt;\u00a00.001), with significant reductions in sensory and functional subdomain scores. In a mixed-cancer population,\n                      <jats:italic>Costus<\/jats:italic>\n                      sp. oil vs. placebo significantly reduced neuropathic pain intensity, as measured by the Visual Analog Scale (VAS) (\n                      <jats:italic>p<\/jats:italic>\n                      = 0.001), and improved Functional Assessment of Cancer Therapy\/Gynecologic Oncology Group - Neurotoxicity (FACT\/GOG-Ntx) scores (\n                      <jats:italic>p<\/jats:italic>\n                      = 0.028). Trials evaluating ajwain cream,\n                      <jats:italic>Citrullus colocynthis<\/jats:italic>\n                      oil, and a multi-compound essential oil formulation did not demonstrate statistically significant improvements in CIPN severity, pain, or quality of life compared with placebo. None of the included studies incorporated quantitative sensory or functional testing. All interventions were well tolerated, with only mild localized skin reactions reported.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>Despite modest benefits from certain herbal treatments in reducing CIPN pain and sensory symptoms, current evidence is limited by small sample sizes, methodological heterogeneity, and the lack of objective outcome measures. Rigorous, adequately powered RCTs with objective CIPN measurements are needed.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2026.1920042","type":"journal-article","created":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T04:28:38Z","timestamp":1790569718000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Topical herbal medicine as treatment for chemotherapy-induced peripheral neuropathy: a systematic review of randomized controlled trials"],"prefix":"10.3389","volume":"16","author":[{"given":"Carrie","family":"Shao","sequence":"first","affiliation":[{"name":"University of Massachusetts Chan Medical School","place":["Worcester, MA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cassie","family":"Shao","sequence":"additional","affiliation":[{"name":"University of Massachusetts Chan Medical School","place":["Worcester, MA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Haggarty","sequence":"additional","affiliation":[{"name":"Lamar Soutter Library, University of Massachusetts Medical School","place":["Worcester, MA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingxiao","family":"Yang","sequence":"additional","affiliation":[{"name":"School of Biological Sciences, College of Science, Nanyang Technological University","place":["Singapore, Singapore"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Bao","sequence":"additional","affiliation":[{"name":"Departments of Supportive Care Medicine and Medical Oncology, City of Hope Comprehensive Cancer Center","place":["Duarte, CA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2014.09.020","article-title":"Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis","volume":"155","author":"Seretny","year":"2014","journal-title":"Pain"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1186\/s12885-023-11546-2","article-title":"Identifying trajectories and predictors of chemotherapy-induced peripheral neuropathy symptoms, physical functioning, and falls across treatment and recovery in adults treated with neurotoxic chemotherapy: the PATTERN observational study protocol (NCT05790538)","volume":"23","author":"Winters-Stone","year":"2023","journal-title":"BMC Cancer"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-014-2255-7","article-title":"Chemotherapy-induced peripheral neuropathy and its association with quality of life: a systematic review","volume":"22","author":"Mols","year":"2014","journal-title":"Support Care Cancer"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.2813","article-title":"Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial","volume":"309","author":"Smith","year":"2013","journal-title":"JAMA"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.01399","article-title":"Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: ASCO guideline update","volume":"38","author":"Loprinzi","year":"2020","journal-title":"J Clin Oncol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2017.00174","article-title":"Pathophysiology of chemotherapy-induced peripheral neuropathy","volume":"10","author":"Starobova","year":"2017","journal-title":"Front Mol Neurosci"},{"key":"B7","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s40199-019-00255-6","article-title":"Medicinal plants and their isolated phytochemicals for the management of chemotherapy-induced neuropathy: therapeutic targets and clinical perspective","volume":"27","author":"Oveissi","year":"2019","journal-title":"Daru"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1607181","article-title":"Traditional herbal medicine for the prevention of chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis with association rule analysis","volume":"16","author":"Kim","year":"2025","journal-title":"Front Pharmacol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/6194184","article-title":"A systematic review of herbal medicine for chemotherapy induced peripheral neuropathy","volume":"2018","author":"Noh","year":"2018","journal-title":"Evid Based Complement Alternat Med"},{"key":"B10","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1186\/s12906-022-03683-1","article-title":"A comprehensive search string informed by an operational definition of complementary, alternative, and integrative medicine for systematic bibliographic database search strategies","volume":"22","author":"Ng","year":"2022","journal-title":"BMC Complement Med Ther"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1093\/9780190247027.003.0002","article-title":"Methodological expectations of cochrane intervention reviews","author":"Higgins","year":"2023"},{"key":"B12","year":"2020"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejon.2020.101827","article-title":"The preliminary effects of henna on chemotherapy-induced peripheral neuropathy in women receiving oxaliplatin-based treatment: a parallel-group, randomized, controlled pilot trial","volume":"48","author":"Arslan","year":"2020","journal-title":"Eur J Oncol Nurs"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.25259\/IJPC_32_2023","article-title":"Exploring the effectiveness of Ajwain cream in treating taxane-induced peripheral neuropathy in cancer patients: a pilot, randomised and double-blind clinical trial","volume":"30","author":"Heydarirad","year":"2024","journal-title":"Indian J Palliat Care"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1089\/acm.2020.0012","article-title":"Topical Costus sp. preparation as palliative care for chemotherapy-induced peripheral neuropathy of patients: a randomized placebo-controlled pilot trial","volume":"26","author":"Heydarirad","year":"2020","journal-title":"J Altern Complement Med"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.pmn.2022.12.008","article-title":"A pilot randomized controlled trial evaluating essential oils for chemotherapy-induced peripheral neuropathy","volume":"24","author":"Langley-Brady","year":"2023","journal-title":"Pain Manag Nurs"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1002\/ptr.6442","article-title":"Efficacy of topical Citrullus colocynthis (bitter apple) extract oil in chemotherapy-induced peripheral neuropathy: a pilot double-blind randomized placebo-controlled clinical trial","volume":"33","author":"Rostami","year":"2019","journal-title":"Phytother Res"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.764473","article-title":"External treatment with Chinese herbal medicine for chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis","volume":"13","author":"Li","year":"2022","journal-title":"Front Pharmacol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1177\/1534735418817833","article-title":"Integrative herbal medicine for chemotherapy-induced peripheral neuropathy and hand-foot syndrome in colorectal cancer: a systematic review and meta-analysis","volume":"18","author":"Liu","year":"2019","journal-title":"Integr Cancer Ther"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/nrn3976","article-title":"The neuroscience of placebo effects: connecting context, learning and health","volume":"16","author":"Wager","year":"2015","journal-title":"Nat Rev Neurosci"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2019.01212","article-title":"The role of tactile stimulation for expectation, perceived treatment assignment and the placebo effect in an experimental nausea paradigm","volume":"13","author":"Aichner","year":"2019","journal-title":"Front Neurosci"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/921802","article-title":"Analgesia is enhanced by providing information regarding good outcomes associated with an odor: placebo effects in aromatherapy","volume":"2013","author":"Masaoka","year":"2013","journal-title":"Evid Based Complement Alternat Med"},{"key":"B23","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3389\/fnmol.2024.1345811","article-title":"Current understanding of the molecular mechanisms of chemotherapy-induced peripheral neuropathy","volume":"10","author":"Chen","year":"2024","journal-title":"Front Mol Neurosci"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1007\/s00210-023-02735-8","article-title":"Therapeutic potential of Lawsonia inermis Linn: a comprehensive overview","volume":"397","author":"Batiha","year":"2024","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1080\/15287394.2020.1866129","article-title":"Safety and bioactivity assessment of aqueous extract of Thai Henna (Lawsonia inermis Linn.) leaf","volume":"84","author":"Khantamat","year":"2021","journal-title":"J Toxicol Environ Health A"},{"key":"B26","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.phytochem.2012.11.010","article-title":"1,5-Diphenylpent-3-en-1-ynes and methyl naphthalene carboxylates from Lawsonia inermis and their anti-inflammatory activity","volume":"88","author":"Liou","year":"2013","journal-title":"Phytochemistry"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1007\/s00210-023-02694-0","article-title":"Saussurea costus (Falc.) Lipsch.: a comprehensive review of its pharmacology, phytochemicals, ethnobotanical uses, and therapeutic potential","volume":"397","author":"Kumari","year":"2024","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2006.12.033","article-title":"Saussurea costus: botanical, chemical and pharmacological review of an ayurvedic medicinal plant","volume":"110","author":"Pandey","year":"2007","journal-title":"J Ethnopharmacol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2014.02.031","article-title":"Costunolide and dehydrocostuslactone, two natural sesquiterpene lactones, ameliorate the inflammatory process associated to experimental pleurisy in mice","volume":"730","author":"Butturini","year":"2014","journal-title":"Eur J Pharmacol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.70718","article-title":"Experimental validation and multimodal spectroscopic profiling of the neuroprotective potential of costunolide in chemotherapy-induced neuropathic pain","volume":"40","author":"Tanveer","year":"2026","journal-title":"J Biochem Mol Toxicol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1111\/cns.70502","article-title":"Dehydrocostus lactone inhibits microglia-mediated neuroinflammation by targeting CYP2A6 to improve ischemic brain injury","volume":"31","author":"Shu","year":"2025","journal-title":"CNS Neurosci Ther"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.626687","article-title":"Neuroinflammatory process involved in different preclinical models of chemotherapy-induced peripheral neuropathy","volume":"11","author":"Fumagalli","year":"2021","journal-title":"Front Immunol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1920042\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T04:28:38Z","timestamp":1790569718000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1920042\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,28]]},"references-count":32,"alternative-id":["10.3389\/fonc.2026.1920042"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1920042","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,28]]},"article-number":"1920042"}}